APA (7th ed.) Citation

J, V., N, F., C, A., MB, H., Z, Ć., A, D., . . . WH, v. H. (2026). Price transparency of cancer medicines: A crucial step towards informed pricing negotiations in the European region. Frontiers in pharmacology, 17, 1736741. https://doi.org/10.3389/fphar.2026.1736741

Chicago Style (17th ed.) Citation

J, Vancoppenolle, et al. "Price Transparency of Cancer Medicines: A Crucial Step Towards Informed Pricing Negotiations in the European Region." Frontiers in Pharmacology 17 (2026): 1736741. https://doi.org/10.3389/fphar.2026.1736741.

MLA (9th ed.) Citation

J, Vancoppenolle, et al. "Price Transparency of Cancer Medicines: A Crucial Step Towards Informed Pricing Negotiations in the European Region." Frontiers in Pharmacology, vol. 17, 2026, p. 1736741, https://doi.org/10.3389/fphar.2026.1736741.